RESMETIROM Drug Record

  • RESMETIROM chembl:CHEMBL3261331

    Alternate Names:

    RESMETIROM
    VIA-3196
    MGL-3196

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antidyslipidaemic agent
    (1 More Sources)

    Publications:

  • RESMETIROM   THRB

    Interaction Score: 1.89

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Novel drug target Established target
    Trial Name VIA-3196
    Mechanism of Interaction Thyroid hormone receptor beta-1 agonist

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions TTD

  • TdgClinicalTrial: VIA-3196

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antidyslipidaemic agent
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • TTD: MGL-3196

    • Version: 2020.06.01

    Alternate Names:
    D03MYO TTD Drug ID

    Drug Info:

    Publications:

  • TTD: VIA-3196

    • Version: 2020.06.01

    Alternate Names:
    D07IFZ TTD Drug ID

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL3261331

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL3261331

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: